SCPH (scPharma) Gross Profit Rate

SCPH (scPharmaceuticals Inc.) - company brandmark

scPharmaceuticals Inc. is implementing closed-loop water systems to reduce its carbon footprint. The gross profit margin reflects profitability trends, while 68.30 records a new level. Revenue is based on the sale of innovative FUROSCIX for home heart failure therapy. Primary risks relate to insurance coverage rates and pump supplies, which are offset by high physician demand.

scPharma (SCPH) Gross Profitability: for the period 07/04/2022 - 10/18/2025

Financial and market metric breakdowns for scPharmaceuticals (SCPH)

- business market valuation indicators:
Fundamental valuation:SCPH, scPharmaceuticals Inc.
Core merchandise of scpharmaceuticals.com

Gross margin measures the portion of revenue remaining after direct production costs, allowing for an assessment of the fundamental efficiency of cost-of-goods-sold management. An analysis of the gross margin for scPharmaceuticals Inc. (SCPH) demonstrates the business's ability to monetize innovation, where growth in this metric will depend directly on successful insurance coverage and the scaling of home injection systems for the treatment of heart failure.

Direct competitors

Gross Profit Margin Haleon PLC (HLN)|Return on Gross Profit KVUE|Gross Profit Margin Verona Pharma Inc. VRNA|Gross Margin MENS|Ligand Pharmaceuticals - Gross Return on Sales|Gross Profitability Amneal AMRX|Gross Sales Margin Perrigo Company PLC|Alvotech Biopharmaceuticals - Gross Margin|Return on Sales by Gross Profit Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Gross Profitability|anipharmaceuticals.com - Gross Profit Rate|Return on Gross Profit MNKD|AMPH: Gross Profit Rate|Gross Profitability pacira.com (PCRX)|Gross Margin ARS Pharma (SPRY)|Theravance Biopharma - Return on Gross Profit|Gross Profit Ratio AQST (Aquestive Therapeutics)|Tectonic - Gross Margin|TNXP - Gross Margin|SXTC: Gross Margin|Eupraxia Pharma - Gross Profit Rate|BHST (bioharvest.com) - Gross Margin|Gross Return on Sales EXOZ (invizyne.com)|Gross Margin ORMP|Return on Sales by Gross Profit Entera Bio|Gross Margin HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Gross Profitability|Cumberland Corp - Gross Margin|QNTM - Gross Margin|FibroGen, Inc. (FGEN) - Gross Profitability|TELO: Gross Profit Ratio|RANI (Rani Therapeutics Inc) - Gross Margin|Gross Profit Margin synergychc.com SNYR|Gross Profitability Rallybio Corp. (RLYB)|LEXX - Gross Profit Margin|Gross Margin PULM (pulmatrix.com)|Gross Profit Ratio PTHL (Pheton)|APM - Gross Profitability|Return on Sales by Gross Profit Lyra Therapeutics Inc LYRA|impactbiomedinc.com (IBO) - Gross Profitability|TNF Pharma (TNFA) - Gross Margin|YCBD (cbdmd.com) - Gross Margin|Return on Gross Profit PainReform (PRFX)|Gross Profitability Altamira Therapeutics (CYTO)|Return on Sales by Gross Profit Lipella Pharma|Optinose - Return on Gross Profit|Return on Sales by Gross Profit pieris.com (PIRS)|PROC - Gross Profitability|Gross Profitability Margin PTPI|QLI: Gross Margin|Gross Profit Margin ACELYRIN Inc. (SLRN)|TFFP (TFF Pharmaceuticals, Inc) - Gross Margin